Home/Filings/4/0001209191-13-026773
4//SEC Filing

Dillaha Larry 4

Accession 0001209191-13-026773

CIK 0001516479other

Filed

May 15, 8:00 PM ET

Accepted

May 16, 3:46 PM ET

Size

5.3 KB

Accession

0001209191-13-026773

Insider Transaction Report

Form 4
Period: 2013-05-14
Dillaha Larry
Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2013-05-14+100,000100,000 total
    Exercise: $10.89Exp: 2023-05-13Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]The option vests in 48 equal monthly installments and will be fully vested and exercisable on May 14, 2017.

Issuer

Insys Therapeutics, Inc.

CIK 0001516479

Entity typeother

Related Parties

1
  • filerCIK 0001360463

Filing Metadata

Form type
4
Filed
May 15, 8:00 PM ET
Accepted
May 16, 3:46 PM ET
Size
5.3 KB